AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Eon rockets past $1 billion valuation in under a year, raising tens of millions more
2
Monday.com founders: “We have everything needed to get to $10 billion in revenue”
3
Israel’s next tech boom: Pioneering the future of global defensetech
4
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
5
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
More news

Clal

5 stories about Clal
הוועידה הכלכלית לאומית אמיר ארגמן אסטרטג השקעות ראשי כלל ביטוח ופיננסים

"Anyone who believes that central banks should halt interest rate hikes lacks an understanding of history"

18.07.23|Irad Atzmon Schmayer
Head of Global Marketing Strategy at Clal Insurance, Amir Argaman, discussed the resurgence of global inflation at Calcalist and Bank Leumi's National Economic Conference
הוועידה הכלכלית לאומית יורם נוה מנכ"ל קבוצת כלל ביטוח ופיננסים

Clal CEO: "2024 will be a great year for Clal"

18.07.23|Tomer Hadar
CEO of Clal Insurance Yoram Naveh spoke at Calcalist and Bank Leumi’s National Economic Conference about Clal’s recent acquisition of the Max credit card company
ועידת Mind the tech TLV עלית כספי המשנה למנכל כלל ביטוח

Insurance Companies Are Not Dinosaurs, Clal Exec Says

27.11.19|Anat Danieli
Elite Caspi, deputy general manager of Israel-based insurance company Clal, spoke Monday at Calcalist’s Mind the Tech conference in Tel Aviv
ועידה כלכלית לאומית 2019 דני נוה יו"ר כלל ביטוח

Israel Should Encourage Institutionals to Invest in Infrastructure, Says Chairman of Insurer Clal

03.09.19|Ran Abramson
Dani Naveh, chairman of Israeli insurance company Clal, spoke Monday at Calcalist and Bank Leumi's National Economic Conference held in Tel Aviv
חדר מיון בית חולים שיבא תל השומר

InSight Biopharmaceuticals Buys Cancer Treatment Company CureTech

28.03.18|Lilach Baumer
As part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced clinical trials